BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17544809)

  • 1. The phylogeny of the complement system and the origins of the classical pathway.
    Dodds AW; Matsushita M
    Immunobiology; 2007; 212(4-5):233-43. PubMed ID: 17544809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of the classical complement pathway: Lamprey orthologue of mammalian C1q acts as a lectin.
    Matsushita M; Matsushita A; Endo Y; Nakata M; Kojima N; Mizuochi T; Fujita T
    Proc Natl Acad Sci U S A; 2004 Jul; 101(27):10127-31. PubMed ID: 15218103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New perspectives on mannan-binding lectin-mediated complement activation.
    Degn SE; Thiel S; Jensenius JC
    Immunobiology; 2007; 212(4-5):301-11. PubMed ID: 17544815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin complement system and pattern recognition.
    Endo Y; Takahashi M; Fujita T
    Immunobiology; 2006; 211(4):283-93. PubMed ID: 16697920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
    Hair PS; Gronemus JQ; Crawford KB; Salvi VP; Cunnion KM; Thielens NM; Arlaud GJ; Rawal N; Krishna NK
    Mol Immunol; 2010 Jan; 47(4):792-8. PubMed ID: 19896716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of the humoral pattern recognition molecule PTX3 with the complement system.
    Doni A; Garlanda C; Bottazzi B; Meri S; Garred P; Mantovani A
    Immunobiology; 2012 Nov; 217(11):1122-8. PubMed ID: 22964239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neutrophil peptide-1 inhibits both the classical and the lectin pathway of complement activation.
    Groeneveld TW; Ramwadhdoebé TH; Trouw LA; van den Ham DL; van der Borden V; Drijfhout JW; Hiemstra PS; Daha MR; Roos A
    Mol Immunol; 2007 Jul; 44(14):3608-14. PubMed ID: 17448537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D; Wiessenberg HD; Hart M; Bruins P; Voskuyl A; Daha MR; Hack CE
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primitive complement system--recognition and activation.
    Fujita T; Endo Y; Nonaka M
    Mol Immunol; 2004 Jun; 41(2-3):103-11. PubMed ID: 15159055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
    Gronemus JQ; Hair PS; Crawford KB; Nyalwidhe JO; Cunnion KM; Krishna NK
    Mol Immunol; 2010; 48(1-3):305-13. PubMed ID: 20728940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
    Skliris A; Happonen KE; Terpos E; Labropoulou V; Børset M; Heinegård D; Blom AM; Theocharis AD
    Eur J Immunol; 2011 Feb; 41(2):437-49. PubMed ID: 21268013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamprey variable lymphocyte receptors mediate complement-dependent cytotoxicity.
    Wu F; Chen L; Liu X; Wang H; Su P; Han Y; Feng B; Qiao X; Zhao J; Ma N; Liu H; Zheng Z; Li Q
    J Immunol; 2013 Feb; 190(3):922-30. PubMed ID: 23293356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second serine protease associated with mannan-binding lectin that activates complement.
    Thiel S; Vorup-Jensen T; Stover CM; Schwaeble W; Laursen SB; Poulsen K; Willis AC; Eggleton P; Hansen S; Holmskov U; Reid KB; Jensenius JC
    Nature; 1997 Apr; 386(6624):506-10. PubMed ID: 9087411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated activation of the classical pathway of complement may compensate for mannose-binding lectin deficiency.
    Roos A; Garred P; Wildenberg ME; Lynch NJ; Munoz JR; Zuiverloon TC; Bouwman LH; Schlagwein N; Fallaux van den Houten FC; Faber-Krol MC; Madsen HO; Schwaeble WJ; Matsushita M; Fujita T; Daha MR
    Eur J Immunol; 2004 Sep; 34(9):2589-98. PubMed ID: 15307191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of immune complexes by the classical pathway.
    Whaley K; Ahmed AE
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of the complement system.
    Farries TC; Atkinson JP
    Immunol Today; 1991 Sep; 12(9):295-300. PubMed ID: 1755941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of C1q and mannan-binding lectin with viruses.
    Thielens NM; Tacnet-Delorme P; Arlaud GJ
    Immunobiology; 2002 Sep; 205(4-5):563-74. PubMed ID: 12396016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of L-ficolin and H-ficolin to apoptotic cells leads to complement activation.
    Kuraya M; Ming Z; Liu X; Matsushita M; Fujita T
    Immunobiology; 2005; 209(9):689-97. PubMed ID: 15804047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of the classical complement pathway with an engineered single-chain Fv to C1q globular heads decreases complement activation by apoptotic cells.
    Duvall MR; Hwang HY; Boackle RJ
    Immunobiology; 2010 May; 215(5):395-405. PubMed ID: 19586684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Complement System of Agnathans.
    Matsushita M
    Front Immunol; 2018; 9():1405. PubMed ID: 29967624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.